Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs ASTRAZENECA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK PHARMA ASTRAZENECA PHARMA GSK PHARMA/
ASTRAZENECA PHARMA
 
P/E (TTM) x 62.2 95.5 65.2% View Chart
P/BV x 18.9 22.7 83.2% View Chart
Dividend Yield % 1.6 0.3 547.6%  

Financials

 GSK PHARMA   ASTRAZENECA PHARMA
EQUITY SHARE DATA
    GSK PHARMA
Mar-23
ASTRAZENECA PHARMA
Mar-23
GSK PHARMA/
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,6843,620 46.5%   
Low Rs1,2312,438 50.5%   
Sales per share (Unadj.) Rs191.9401.2 47.8%  
Earnings per share (Unadj.) Rs35.939.7 90.3%  
Cash flow per share (Unadj.) Rs39.846.2 86.0%  
Dividends per share (Unadj.) Rs32.0016.00 200.0%  
Avg Dividend yield %2.20.5 415.7%  
Book value per share (Unadj.) Rs102.9234.4 43.9%  
Shares outstanding (eoy) m169.4125.00 677.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.67.5 100.6%   
Avg P/E ratio x40.676.3 53.3%  
P/CF ratio (eoy) x36.765.5 55.9%  
Price / Book Value ratio x14.212.9 109.6%  
Dividend payout %89.240.3 221.5%   
Avg Mkt Cap Rs m246,85875,718 326.0%   
No. of employees `000NANA-   
Total wages/salary Rs m5,9502,591 229.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m32,51710,030 324.2%  
Other income Rs m1,007261 385.7%   
Total revenues Rs m33,52410,291 325.8%   
Gross profit Rs m8,0331,249 643.2%  
Depreciation Rs m658163 404.5%   
Interest Rs m186 287.6%   
Profit before tax Rs m8,3641,341 623.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,288348 657.2%   
Profit after tax Rs m6,076993 612.0%  
Gross profit margin %24.712.5 198.4%  
Effective tax rate %27.426.0 105.4%   
Net profit margin %18.79.9 188.8%  
BALANCE SHEET DATA
Current assets Rs m24,9439,359 266.5%   
Current liabilities Rs m13,2644,844 273.8%   
Net working cap to sales %35.945.0 79.8%  
Current ratio x1.91.9 97.3%  
Inventory Days Days9749 196.7%  
Debtors Days Days21639 551.9%  
Net fixed assets Rs m6,9882,061 339.0%   
Share capital Rs m1,69450 3,388.1%   
"Free" reserves Rs m15,7355,811 270.8%   
Net worth Rs m17,4305,861 297.4%   
Long term debt Rs m00-   
Total assets Rs m31,93011,421 279.6%  
Interest coverage x462.6213.9 216.3%   
Debt to equity ratio x00-  
Sales to assets ratio x1.00.9 116.0%   
Return on assets %19.18.7 218.2%  
Return on equity %34.916.9 205.8%  
Return on capital %48.123.0 209.2%  
Exports to sales %00-   
Imports to sales %48.137.4 128.7%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m15,6303,747 417.1%   
Fx inflow Rs m1,622612 265.0%   
Fx outflow Rs m15,6303,747 417.1%   
Net fx Rs m-14,008-3,135 446.8%   
CASH FLOW
From Operations Rs m4,842583 830.7%  
From Investments Rs m8,079181 4,460.8%  
From Financial Activity Rs m-15,433-245 6,304.4%  
Net Cashflow Rs m-2,512519 -483.9%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 75.0 100.0%  
Indian inst/Mut Fund % 11.6 5.4 213.7%  
FIIs % 2.9 2.7 110.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 25.0 100.0%  
Shareholders   114,663 29,032 395.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on GSK Pharma vs ASTRAZENECA PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

GSK Pharma vs ASTRAZENECA PHARMA Share Price Performance

Period GSK Pharma ASTRAZENECA PHARMA S&P BSE HEALTHCARE
1-Day 3.26% 0.01% 1.18%
1-Month -9.77% -3.61% -0.75%
1-Year 52.63% 59.20% 61.82%
3-Year CAGR 10.89% 20.50% 18.16%
5-Year CAGR 8.44% 22.18% 19.79%

* Compound Annual Growth Rate

Here are more details on the GSK Pharma share price and the ASTRAZENECA PHARMA share price.

Moving on to shareholding structures...

The promoters of GSK Pharma hold a 75.0% stake in the company. In case of ASTRAZENECA PHARMA the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GSK Pharma and the shareholding pattern of ASTRAZENECA PHARMA.

Finally, a word on dividends...

In the most recent financial year, GSK Pharma paid a dividend of Rs 32.0 per share. This amounted to a Dividend Payout ratio of 89.2%.

ASTRAZENECA PHARMA paid Rs 16.0, and its dividend payout ratio stood at 40.3%.

You may visit here to review the dividend history of GSK Pharma, and the dividend history of ASTRAZENECA PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.